Scientific Reports · 2018 · 23 citations · 26 references
Life SciencesImmunologyMolecular BiologyGene ExpressionSignal TransductionTranscriptional RegulationIge-mediated AllergyMammalian ImmunologyMast Cell ActivationType I HypersensitivityBone Marrow - Derived CellsIge-mediated ActivationIge-mediated HypersensitivityIge-mediated Mast Cell ResponsesIge-mediated ResponsesMast Cell BiologyMast Cell Transcriptional RegulationPassive Cutaneous Anaphylaxis
PU.1 is a hematopoietic cell-specific transcription factor. In the current study, we investigated the role of PU.1 in the gene expression and the function of mouse mast cells (MCs) in vitro and in vivo. When PU.1 siRNA was introduced into bone marrow-derived MCs (BMMCs), IgE-mediated activation was reduced, and the Syk and FcεRIβ mRNA levels were significantly decreased. As the regulatory mechanism of the Syk gene is largely unknown, we performed promoter analysis and found that PU.1 transactivated the Syk promoter through direct binding to a cis-element in the 5'-untranslated region. The involvement of PU.1 in the Syk promoter was also observed in mouse dendritic cells and human MCs, suggesting that the relationship between PU.1 and Syk is common in mammals and in hematopoietic lineages. When antigen was administrated intravenously after the transfusion of siRNA-transfected BMMCs in the mouse footpad, the footpad thickening was significantly suppressed by PU.1 knockdown. Finally, administration of the immunomodulator pomalidomide suppressed passive systemic anaphylaxis of mice. Taken together, these results indicate that PU.1 knockdown might be an efficacious strategy for the prevention of MC-mediated allergic diseases.
26
Arnold S. Kirshenbaum, Cem Akin, Yalin Wu et al. · Leukemia Research · 2003 · 508 citations
Masao Yamaguchi, Chris S. Lantz, Hans C. Oettgen et al. · The Journal of Experimental Medicine · 1997 · 449 citations · Full text
Life Sciences, Immunology, Allergy +16
Regulation of Mast Cell Survival by IgE
Koichi Asai, Jiro Kitaura, Yuko Kawakami et al. · Immunity · 2001 · 330 citations · Full text
Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1
Gülsüm Anderson, Margarete Gries, Noriyoshi Kurihara et al. · Blood · 2005 · 149 citations